U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07182214) titled 'An Observational Study on the Assessment of Lung Cancer Using Liquid Biopsy for Collecting miRNA Expression Profile and DNA Methylation Biomarkers.' on Sept. 11.

Brief Summary: The purpose of this study is to observe whether miRNA and DNA methylation collected through liquid biopsy can serve as a biomarker for evaluating lung cancer.

Study Start Date: May 05, 2024

Study Type: OBSERVATIONAL

Condition: Lung Cancer

Intervention: OTHER: Collect blood sample

Collect venous blood sample from subjects prior fasting, any operation or treatment

Recruitment Status: RECRUITING

Sponsor: Pharus Taiwan, Inc.

Published by HT Digital Con...